Subscribe to Newsletter

Search

Reset Filter

3931 search results for ‘*’

Discovery & Development Drug Discovery

Combination Revelation

| Rob Coker | 2 min read

Could J&J’s combination treatment for PAH bridge the gaps between guidelines and practice, while easing the burden on patients?

Manufacture Drug Discovery

New Ways to Discover Novel Peptide Therapeutics

| Sponsored by Biosynth

This webinar focuses on challenges in peptide drug discovery and how Biosynth’s CLIPS (Chemical Linkage of Peptides onto Scaffolds) peptide phage display technology tackles these challenges.

Discovery & Development Clinical Trials

For Faster Trials, Improve Feasibility

| Christine Senn | 6 min read

The burden on clinical trials designers and healthcare professionals can only be eased by fixing a broken process: trial feasibility.

Discovery & Development Clinical Trials

Regeneron on the Digital Age of Clinical Trials

| 6 min read

The world is taking more interest in clinical trials. How are clinical trials adapting? Regeneron’s Bari Kowal keeps us updated.

Discovery & Development Formulation

MR Control

| Asma Patel, John McDermott | 4 min read

Developing modified release formulations can be complex – but a translational pharmaceutics approach can smooth the path

Manufacture Advanced Medicine

Enter Exon Editing

| Michael Ehlers | 4 min read

If we can edit RNA at the kilobase scale, we can treat more diseases at the genetic level

Manufacture Technology and Equipment

Nominations Open for The Medicine Maker 2024 Innovation Awards

| 2 min read

Our annual Innovation Awards celebrate the top launches of the year for drug development and manufacturing technology.

Business & Regulation Supply Chain

The Intersection of Sustainability

| Sreedhar Patnala | 3 min read

How pharmaceutical companies are aligning their sustainability goals with the complexities of the modern supply chain

Manufacture Technology and Equipment

An Analytical Eye for mRNA

| 5 min read

How a new collaboration looks to improve analytical testing for mRNA products.

Discovery & Development Drug Discovery

ADCs Versus Solid Tumors

| Stephanie Vine | 3 min read

Drug developers place their bets on the ROR-1 antigen in the battle against solid tumors.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register